VIVS Stock Price, Chart, Stats & News

VivoSim Labs, Inc.
Save
2.95M
Market cap
0.66x
Current P/E
–
Forward P/E
VIVS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -8066.20% |
Pretax margin | -862.68% |
Net margin | -864.08% |
Effective tax rate | -0.16% |
ROA | -17.63% |
ROE | -15.56% |
D/E | 0.13x |
Interest coverage ratio | -881.08x |
VIVS valuation
P/E | 0.66x |
P/S | 29.75x |
P/B | 0.53x |
P/CF | -0.22x |
P/FCF | -0.40x |
P/OCF | -0.22x |
PEG | -0.06x |
EV multiple | -8.11x |
About
VivoSim Labs, Inc. is a biotechnology company dedicated to developing sophisticated 3D tissue models designed to replicate key aspects of human diseases. At the heart of their operations is a proprietary 3D human tissue platform, which incorporates their advanced NovoGen Bioprinters. These automated devices are engineered to construct intricate 3D living tissues using mammalian cells, alongside complementary technologies vital for preparing specialized bio-inks and for the precise bioprinting of multi-cellular tissues with complex architectural designs.
Similar securities
Based on sector and market capitalization
Report issue










